Pharmacokinetics of glimepiride and cytochrome P450 2C9 genetic polymorphisms.
Wang
Rui
R
Chen
Kun
K
Wen
Si-yuan
SY
Li
Jian
J
Wang
Sheng-qi
SQ
D000284:Administration, Oral; D000483:Alleles; D019540:Area Under Curve; D001189:Aryl Hydrocarbon Hydroxylases / Q000187:drug effects / Q000235:genetics* / Q000378:metabolism; D044466:Asian People / Q000235:genetics; D065729:Cytochrome P-450 CYP2C9; D006207:Half-Life; D006579:Heterozygote; D006801:Humans; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D011110:Polymorphism, Genetic; D013453:Sulfonylurea Compounds / Q000008:administration & dosage / Q000378:metabolism / Q000493:pharmacokinetics*
D013453:Sulfonylurea Compounds; C057619:glimepiride; C450260:CYP2C9 protein, human; D065729:Cytochrome P-450 CYP2C9; D001189:Aryl Hydrocarbon Hydroxylases